Passage BIO, Inc. — Director's Dealing 2021

Aug 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2021-08-23

Reporting Person: King Simona (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-23	Employee Stock Option (Right to Buy)	$11.43	A	360000	Acquired	2031-08-22	Common Stock (360000)	Direct

Footnotes

F1: The stock option vests as to 25% of the total shares on August 23, 2022, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on August 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.